These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 34090697)

  • 1. Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
    Shingai M; Nomura N; Sekiya T; Ohno M; Fujikura D; Handabile C; Omori R; Ohara Y; Nishimura T; Endo M; Kimachi K; Mitsumata R; Ikeda T; Kitayama H; Hatanaka H; Sobue T; Muro F; Suzuki S; Thanh Nguyen C; Ishigaki H; Nakayama M; Mori Y; Itoh Y; Koutsakos M; Chua BY; Kedzierska K; Brown LE; Jackson DC; Ogasawara K; Kino Y; Kida H
    Vaccine; 2021 Jun; 39(29):3940-3951. PubMed ID: 34090697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
    Sekiya T; Mifsud EJ; Ohno M; Nomura N; Sasada M; Fujikura D; Daito T; Shingai M; Ohara Y; Nishimura T; Endo M; Mitsumata R; Ikeda T; Hatanaka H; Kitayama H; Motokawa K; Sobue T; Suzuki S; Itoh Y; Brown LE; Ogasawara K; Kino Y; Kida H
    Vaccine; 2019 Apr; 37(15):2158-2166. PubMed ID: 30857932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.
    Chua BY; Sekiya T; Koutsakos M; Nomura N; Rowntree LC; Nguyen THO; McQuilten HA; Ohno M; Ohara Y; Nishimura T; Endo M; Itoh Y; Habel JR; Selva KJ; Wheatley AK; Wines BD; Hogarth PM; Kent SJ; Chung AW; Jackson DC; Brown LE; Shingai M; Kedzierska K; Kida H
    PLoS Pathog; 2022 Oct; 18(10):e1010891. PubMed ID: 36206307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques.
    Ohno M; Sagata M; Sekiya T; Nomura N; Shingai M; Endo M; Kimachi K; Suzuki S; Thanh Nguyen C; Nakayama M; Ishigaki H; Ogasawara K; Itoh Y; Kino Y; Kida H
    Vaccine; 2023 Jan; 41(3):787-794. PubMed ID: 36526501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection.
    Handabile C; Sekiya T; Nomura N; Ohno M; Kawakita T; Shingai M; Kida H
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
    Shiohara M; Suzuki S; Shichinohe S; Ishigaki H; Nakayama M; Nomura N; Shingai M; Sekiya T; Ohno M; Iida S; Kawai N; Kawahara M; Yamagishi J; Ito K; Mitsumata R; Ikeda T; Motokawa K; Sobue T; Kida H; Ogasawara K; Itoh Y
    Vaccine; 2022 Jun; 40(30):4026-4037. PubMed ID: 35641357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.
    Geeraedts F; Goutagny N; Hornung V; Severa M; de Haan A; Pool J; Wilschut J; Fitzgerald KA; Huckriede A
    PLoS Pathog; 2008 Aug; 4(8):e1000138. PubMed ID: 18769719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
    Handabile C; Ohno M; Sekiya T; Nomura N; Kawakita T; Kawahara M; Endo M; Nishimura T; Okumura M; Toba S; Sasaki M; Orba Y; Chua BY; Rowntree LC; Nguyen THO; Shingai M; Sato A; Sawa H; Ogasawara K; Kedzierska K; Kida H
    Sci Rep; 2024 Feb; 14(1):4204. PubMed ID: 38378856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine.
    van de Sandt CE; Kreijtz JH; Geelhoed-Mieras MM; Vogelzang-van Trierum SE; Nieuwkoop NJ; van de Vijver DA; Fouchier RA; Osterhaus AD; Morein B; Rimmelzwaan GF
    Vaccine; 2014 Sep; 32(43):5614-23. PubMed ID: 25140929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine.
    Geeraedts F; ter Veer W; Wilschut J; Huckriede A; de Haan A
    Vaccine; 2012 Oct; 30(45):6501-7. PubMed ID: 22841974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection.
    Kim YH; Bang YJ; Park HJ; Li Ko H; Park SI; Hwang KA; Kim H; Nam JH
    Vaccine; 2020 Sep; 38(39):6141-6152. PubMed ID: 32739118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
    Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
    Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.
    Budimir N; Meijerhof T; Wilschut J; Huckriede A; de Haan A
    Vaccine; 2010 Dec; 28(52):8280-7. PubMed ID: 20965298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Sato A; Coban C; Ishii KJ
    Vaccine; 2014 May; 32(25):3004-9. PubMed ID: 24721532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9).
    Chu DH; Sakoda Y; Nishi T; Hiono T; Shichinohe S; Okamatsu M; Kida H
    Vaccine; 2014 Jun; 32(28):3473-9. PubMed ID: 24793949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis.
    Ato M; Takahashi Y; Fujii H; Hashimoto S; Kaji T; Itamura S; Horiuchi Y; Arakawa Y; Tashiro M; Takemori T
    Vaccine; 2013 Apr; 31(17):2184-90. PubMed ID: 23434386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
    Keijzer C; Haijema BJ; Meijerhof T; Voorn P; de Haan A; Leenhouts K; van Roosmalen ML; van Eden W; Broere F
    Vaccine; 2014 May; 32(24):2904-10. PubMed ID: 24598720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.